What sector does Transcode Therapeutics Inc (RNAZ) operate in?
Transcode Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Transcode Therapeutics Inc (RNAZ) current stock price?
As of the latest data, Transcode Therapeutics Inc stock price is $8.21, with a previous close of $8.57. Transcode Therapeutics Inc lost -$0.36 in the last trading session, representing a -4.18% loss.
What is Transcode Therapeutics Inc (RNAZ) current market capitalization?
Transcode Therapeutics Inc market cap is approximately 7.53 million.
What is Transcode Therapeutics Inc (RNAZ) Earnings Per Share (EPS)?
The trailing EPS is -$236.52, and the forward EPS is -$0.32.
Does Transcode Therapeutics Inc (RNAZ) pay dividends?
No. Transcode Therapeutics Inc does not pay a dividend.
What is Transcode Therapeutics Inc (RNAZ) beta (volatility) score?
Transcode Therapeutics Inc has a beta of 1.502, suggesting it is more volatile than the market.